Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antibacterial Agents
New metronidazole vaginal gel, 0.75% for bacterial vaginosis introduced
November 18th, 2005
Upsher-Smith Laboratories, Inc. has introduced new Vandazole (metronidazole vaginal gel, 0.75%) for treatment of bacterial vaginosis in non-pregnant patients. Available in 70-gram tubes with five vaginal applicators, Vandazole Vaginal Gel is an alternative for treatment of bacterial vaginosis in the metronidazole vaginal gel market. Vandazole Vaginal Gel was developed, and will be manufactured for Upsher-Smith Laboratories, Inc. under an exclusive agreement, by Teva Pharmaceuticals USA. Upsher-Smith Laboratories, Inc. will utilize its sales and marketing resources, including sales force, national conventions and professional advertising, to promote...
Source: Drug Week (2005-11-18)
|
